Literature DB >> 34870949

Letter to the Editor: Can Topical Vancomycin Prevent Periprosthetic Joint Infection in Hip and Knee Arthroplasty? A Systematic Review.

Bart G Pijls1, Rob G H H Nelissen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34870949      PMCID： PMC8747493          DOI： 10.1097/CORR.0000000000002075

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  5 in total

1.  Absence of evidence is not evidence of absence.

Authors:  D G Altman; J M Bland
Journal:  BMJ       Date:  1995-08-19

2.  The Otto Aufranc Award: Modifiable versus nonmodifiable risk factors for infection after hip arthroplasty.

Authors:  Guy Maoz; Michael Phillips; Joseph Bosco; James Slover; Anna Stachel; Ifeoma Inneh; Richard Iorio
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

Review 3.  Patient-related medical risk factors for periprosthetic joint infection of the hip and knee.

Authors:  Aleeson Eka; Antonia F Chen
Journal:  Ann Transl Med       Date:  2015-09

4.  Can Topical Vancomycin Prevent Periprosthetic Joint Infection in Hip and Knee Arthroplasty? A Systematic Review.

Authors:  Murray T Wong; Sarup S Sridharan; Erin M Davison; Richard Ng; Nicholas M Desy
Journal:  Clin Orthop Relat Res       Date:  2021-08-01       Impact factor: 4.755

5.  Proton-pump inhibitors are associated with increased risk of prosthetic joint infection in patients with total hip arthroplasty: a case-cohort study.

Authors:  Maarten M Bruin; Ruud L M Deijkers; Roos Bazuin; Erika P M Elzakker; Bart G Pijls
Journal:  Acta Orthop       Date:  2021-05-12       Impact factor: 3.717
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.